Population-based survey of SARS-CoV-2 infection and immune response

  • Funded by National Institutes of Health (NIH)
  • Total publications:9 publications

Grant number: 3R01AI143875-02S1

Grant search

Key facts

  • Disease

  • Start & end year

  • Known Financial Commitments (USD)

  • Funder

    National Institutes of Health (NIH)
  • Principle Investigator

  • Research Location

    United States of America, Americas
  • Lead Research Institution

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory


  • Special Interest Tags


  • Study Subject


  • Clinical Trial Details


  • Broad Policy Alignment


  • Age Group


  • Vulnerable Population


  • Occupations of Interest



To have an optimal response to the COVID-19 epidemic, it is important to understand the proportion of adultsin the United States may have the virus that causes COVID-19, and how many have had it in the past and mayhave immunity. Currently available data are limited because the impact of asymptomatic and mildlysymptomatic cases is unclear and many people are unable to access a test due to rationing, or may beotherwise unwilling to go for testing or care. This study will address this problem by conducting a nationalprobability sample, where each address may be selected by chance, to develop estimates of the proportion ofadults in the United States that are infected with the virus that causes COVID-19, and the proportion that hashad the disease in the past and may now have immunity. We will use home-based testing techniques tofacilitate participation in this national study. We will also use surveys to better understand participants in oursample. With these estimates, we will conduct disease modeling to understand different scenarios of theepidemic. We will also develop a website to provide information and data to the public.

Publicationslinked via Europe PMC

Last Updated:40 minutes ago

View all publications at Europe PMC

COVID-19 vaccine attitudes among a majority black sample in the Southern US: public health implications from a qualitative study.

Post-lockdown changes of age-specific susceptibility and its correlation with adherence to social distancing measures.

Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020.

A framework for monitoring population immunity to SARS-CoV-2.

SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California.

A modeling study to inform screening and testing interventions for the control of SARS-CoV-2 on university campuses.

Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA.

At-home self-collection of saliva, oropharyngeal swabs and dried blood spots for SARS-CoV-2 diagnosis and serology: Post-collection acceptability of specimen collection process and patient confidence in specimens.

Willingness to Seek Diagnostic Testing for SARS-CoV-2 With Home, Drive-through, and Clinic-Based Specimen Collection Locations.